{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT02149719",
      "orgStudyIdInfo": {
        "id": "15SM2492"
      },
      "secondaryIdInfos": [
        {
          "id": "ACTRN12614000265673",
          "type": "REGISTRY",
          "domain": "Australian New Zealand Clinical Trials Registry"
        }
      ],
      "organization": {
        "fullName": "Imperial College London",
        "class": "OTHER"
      },
      "briefTitle": "Boiled Peanut Oral Immunotherapy for the Treatment of Peanut Allergy: a Pilot Study",
      "officialTitle": "Phase 2 Randomised Study of Oral Immunotherapy Using Boiled Peanut to Induce Desensitisation in Children With Challenge-proven, IgE-mediated Peanut Allergy",
      "acronym": "BOPI-1"
    },
    "statusModule": {
      "statusVerifiedDate": "2024-03",
      "overallStatus": "COMPLETED",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2015-05",
        "type": "ACTUAL"
      },
      "primaryCompletionDateStruct": {
        "date": "2020-11-30",
        "type": "ACTUAL"
      },
      "completionDateStruct": {
        "date": "2022-05-12",
        "type": "ACTUAL"
      },
      "studyFirstSubmitDate": "2014-05-24",
      "studyFirstSubmitQcDate": "2014-05-24",
      "studyFirstPostDateStruct": {
        "date": "2014-05-29",
        "type": "ESTIMATED"
      },
      "resultsFirstSubmitDate": "2023-04-24",
      "resultsFirstSubmitQcDate": "2024-03-27",
      "resultsFirstPostDateStruct": {
        "date": "2024-03-29",
        "type": "ACTUAL"
      },
      "lastUpdateSubmitDate": "2024-03-27",
      "lastUpdatePostDateStruct": {
        "date": "2024-03-29",
        "type": "ACTUAL"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "type": "PRINCIPAL_INVESTIGATOR",
        "investigatorFullName": "Paul Turner",
        "investigatorTitle": "Principal Investigator",
        "investigatorAffiliation": "Imperial College London"
      },
      "leadSponsor": {
        "name": "Imperial College London",
        "class": "OTHER"
      },
      "collaborators": [
        {
          "name": "University of Sydney",
          "class": "OTHER"
        },
        {
          "name": "National Institute for Health Research, United Kingdom",
          "class": "OTHER_GOV"
        }
      ]
    },
    "oversightModule": {
      "oversightHasDmc": true
    },
    "descriptionModule": {
      "briefSummary": "Peanut allergy is increasingly common, especially in countries such as UK and Australia. There is currently no accepted routine clinical therapy to cure peanut allergy. Recently studies have looked at desensitising people with peanut allergy by giving them small daily doses of roasted peanut. Although this therapy works for some people, its effects are not generally long lasting and it is associated with many side effects during protocol, resulting in a significant rate of drop-outs.\n\nPilot data suggests that boiled peanut is less immunogenic than roasted peanut, and may therefore provide a safer way of inducing desensitisation in patients who are allergic to roasted peanut, by first inducing tolerance to boiled peanut.\n\nStudy hypothesis: Increasing doses of boiled peanut can induce desensitisation to roasted peanut, in peanut-allergic individuals."
    },
    "conditionsModule": {
      "conditions": [
        "IgE Mediated Peanut Allergy"
      ],
      "keywords": [
        "Peanut allergy",
        "Desensitisation",
        "Safety"
      ]
    },
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "designInfo": {
        "allocation": "RANDOMIZED",
        "interventionModel": "CROSSOVER",
        "primaryPurpose": "TREATMENT",
        "maskingInfo": {
          "masking": "NONE"
        }
      },
      "enrollmentInfo": {
        "count": 47,
        "type": "ACTUAL"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "Desensitisation to peanut",
          "type": "EXPERIMENTAL",
          "description": "Desensitisation using boiled peanut",
          "interventionNames": [
            "Other: Desensitisation using boiled peanut"
          ]
        },
        {
          "label": "Control",
          "type": "EXPERIMENTAL",
          "description": "Subjects allocated to the control group will undergo routine care for 12 months, following which they will be offered the active treatment with boiled peanut (as a one-way cross-over intervention).",
          "interventionNames": [
            "Other: Desensitisation using boiled peanut (deferred start)"
          ]
        }
      ],
      "interventions": [
        {
          "type": "OTHER",
          "name": "Desensitisation using boiled peanut",
          "armGroupLabels": [
            "Desensitisation to peanut"
          ]
        },
        {
          "type": "OTHER",
          "name": "Desensitisation using boiled peanut (deferred start)",
          "armGroupLabels": [
            "Control"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "Desensitisation to >1.4g (Roasted) Peanut Protein at Food Challenge",
          "description": "The proportion of participants who tolerate 1.4g (or more) roasted peanut protein after 12 months of OIT as assessed by DBPCFC, in the active vs control group.",
          "timeFrame": "12 months"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Change in Threshold to Roasted Peanut After 6 and 12 Months of OIT",
          "description": "Relative change in clinical threshold (No observed adverse event level, NOAEL; Lowest observed adverse event level, LOAEL) to roasted peanut at 6 and 12 months.",
          "timeFrame": "6 and 12 months after study intervention"
        },
        {
          "measure": "Sustained Unresponsiveness After 4 Week Cessation of Maintenance OIT",
          "description": "Rate of sustained unresponsiveness after 4 week cessation of maintenance OIT at 1 year.",
          "timeFrame": "After 1 year of OIT"
        },
        {
          "measure": "Safety, Incidence of Adverse Event",
          "description": "Incidence of adverse allergic events during desensitisation protocol",
          "timeFrame": "12 months"
        },
        {
          "measure": "Quality of Life Measures",
          "description": "Quality of Life assessment and how this changes during peanut desensitisation.",
          "timeFrame": "6, 12 and 24 months"
        },
        {
          "measure": "Study Compliance",
          "description": "Compliance with study protocol",
          "timeFrame": "12 months"
        },
        {
          "measure": "Immunological Outcomes",
          "description": "Immunological outcome measures pre-, during and post- 12 months of OIT",
          "timeFrame": "Pre, 3, 6, and 12 months post start of OIT"
        }
      ],
      "otherOutcomes": [
        {
          "measure": "Change in Threshold in Peanut-allergic Subjects Found to be Tolerant to Boiled Peanut at Baseline",
          "description": "Change in threshold in peanut-allergic subjects found to be tolerant to boiled peanut at baseline, as determined by double-blind, placebo-controlled food challenges pre- and post- desensitisation.",
          "timeFrame": "12 months"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n* IgE-mediated peanut allergy, confirmed at double-blind placebo-controlled food challenge\n* Tolerant to at least 1/4 boiled peanut (boiled for 4 hours) at open food challenge.\n* Informed consent of parent/legal guardian and patient assent\n\nExclusion Criteria:\n\n* Allergic to 1/4 boiled peanut at PCFC\n* Tolerates â‰¥1.4 g roasted peanut protein at entry PCFC\n* Unstable asthma\n* Unwilling or unable to fulfil study requirements\n* Undergoing other forms of immunotherapy (e.g. SCIT or SLIT to aeroallergens)\n* Previous admission to ICU for management of allergic reaction to peanut\n* Clinically significant chronic illness (other than asthma, rhinitis or eczema).\n* Undergoing subcutaneous or sublingual immunotherapy and within the first year of therapy, for respiratory allergy.\n* Subjects receiving anti-IgE therapy, oral immunosupressants, beta-blocker or ACE inhibitor therapy.",
      "healthyVolunteers": false,
      "sex": "ALL",
      "minimumAge": "8 Years",
      "maximumAge": "16 Years",
      "stdAges": [
        "CHILD"
      ]
    },
    "contactsLocationsModule": {
      "overallOfficials": [
        {
          "name": "Dianne E Campbell, FRACP PhD",
          "affiliation": "The Children's Hospital at Westmead, Australia",
          "role": "STUDY_CHAIR"
        },
        {
          "name": "Sam Mehr, FRACP",
          "affiliation": "The Children's Hospital at Westmead, Australia",
          "role": "STUDY_DIRECTOR"
        },
        {
          "name": "Paul J Turner, FRACP PhD",
          "affiliation": "Imperial College London",
          "role": "PRINCIPAL_INVESTIGATOR"
        }
      ],
      "locations": [
        {
          "facility": "Imperial College London / Imperial College Healthcare NHS Trust",
          "city": "London",
          "zip": "W2 1NY",
          "country": "United Kingdom",
          "geoPoint": {
            "lat": 51.50853,
            "lon": -0.12574
          }
        }
      ]
    },
    "referencesModule": {
      "references": [
        {
          "pmid": "33715235",
          "type": "DERIVED",
          "citation": "Turner PJ, Ruiz-Garcia M, Patel N, Abrantes G, Burrell S, Vazquez-Ortiz M, Skypala I, Durham SR, Boyle RJ. Delayed symptoms and orthostatic intolerance following peanut challenge. Clin Exp Allergy. 2021 May;51(5):696-702. doi: 10.1111/cea.13865. Epub 2021 Mar 21."
        },
        {
          "pmid": "32948514",
          "type": "DERIVED",
          "citation": "Burrell S, Patel N, Vazquez-Ortiz M, Campbell DE, DunnGalvin A, Turner PJ. Self-administration of adrenaline for anaphylaxis during in-hospital food challenges improves health-related quality of life. Arch Dis Child. 2021 Jun;106(6):558-563. doi: 10.1136/archdischild-2020-319906. Epub 2020 Sep 18."
        }
      ]
    }
  },
  "resultsSection": {
    "participantFlowModule": {
      "groups": [
        {
          "id": "FG000",
          "title": "Desensitisation to Peanut",
          "description": "Desensitisation using boiled peanut"
        },
        {
          "id": "FG001",
          "title": "Control",
          "description": "Subjects allocated to the control group will undergo routine care for 12 months, following which they will be offered the active treatment with boiled peanut (as a one-way cross-over intervention).\n\nDesensitisation using boiled peanut (deferred start)"
        }
      ],
      "periods": [
        {
          "title": "Overall Study",
          "milestones": [
            {
              "type": "STARTED",
              "achievements": [
                {
                  "groupId": "FG000",
                  "numSubjects": "32"
                },
                {
                  "groupId": "FG001",
                  "numSubjects": "15"
                }
              ]
            },
            {
              "type": "COMPLETED",
              "achievements": [
                {
                  "groupId": "FG000",
                  "numSubjects": "24"
                },
                {
                  "groupId": "FG001",
                  "numSubjects": "14"
                }
              ]
            },
            {
              "type": "NOT COMPLETED",
              "achievements": [
                {
                  "groupId": "FG000",
                  "numSubjects": "8"
                },
                {
                  "groupId": "FG001",
                  "numSubjects": "1"
                }
              ]
            }
          ]
        }
      ]
    },
    "baselineCharacteristicsModule": {
      "groups": [
        {
          "id": "BG000",
          "title": "Desensitisation to Peanut",
          "description": "Desensitisation using boiled peanut\n\nDesensitisation using boiled peanut"
        },
        {
          "id": "BG001",
          "title": "Control",
          "description": "Subjects allocated to the control group will undergo routine care for 12 months, following which they will be offered the active treatment with boiled peanut (as a one-way cross-over intervention).\n\nDesensitisation using boiled peanut (deferred start)"
        },
        {
          "id": "BG002",
          "title": "Total",
          "description": "Total of all reporting groups"
        }
      ],
      "denoms": [
        {
          "units": "Participants",
          "counts": [
            {
              "groupId": "BG000",
              "value": "32"
            },
            {
              "groupId": "BG001",
              "value": "15"
            },
            {
              "groupId": "BG002",
              "value": "47"
            }
          ]
        }
      ],
      "measures": [
        {
          "title": "Age, Continuous",
          "paramType": "MEDIAN",
          "dispersionType": "FULL_RANGE",
          "unitOfMeasure": "years",
          "classes": [
            {
              "denoms": [
                {
                  "units": "Participants",
                  "counts": [
                    {
                      "groupId": "BG000",
                      "value": "32"
                    },
                    {
                      "groupId": "BG001",
                      "value": "15"
                    },
                    {
                      "groupId": "BG002",
                      "value": "47"
                    }
                  ]
                }
              ],
              "categories": [
                {
                  "measurements": [
                    {
                      "groupId": "BG000",
                      "value": "12.5",
                      "lowerLimit": "8",
                      "upperLimit": "16.9"
                    },
                    {
                      "groupId": "BG001",
                      "value": "12.5",
                      "lowerLimit": "8.9",
                      "upperLimit": "15.4"
                    },
                    {
                      "groupId": "BG002",
                      "value": "12.5",
                      "lowerLimit": "8",
                      "upperLimit": "16.9"
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "title": "Sex: Female, Male",
          "paramType": "COUNT_OF_PARTICIPANTS",
          "unitOfMeasure": "Participants",
          "classes": [
            {
              "denoms": [
                {
                  "units": "Participants",
                  "counts": [
                    {
                      "groupId": "BG000",
                      "value": "32"
                    },
                    {
                      "groupId": "BG001",
                      "value": "15"
                    },
                    {
                      "groupId": "BG002",
                      "value": "47"
                    }
                  ]
                }
              ],
              "categories": [
                {
                  "title": "Female",
                  "measurements": [
                    {
                      "groupId": "BG000",
                      "value": "11"
                    },
                    {
                      "groupId": "BG001",
                      "value": "9"
                    },
                    {
                      "groupId": "BG002",
                      "value": "20"
                    }
                  ]
                },
                {
                  "title": "Male",
                  "measurements": [
                    {
                      "groupId": "BG000",
                      "value": "21"
                    },
                    {
                      "groupId": "BG001",
                      "value": "6"
                    },
                    {
                      "groupId": "BG002",
                      "value": "27"
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "title": "Race and Ethnicity Not Collected",
          "populationDescription": "Race and Ethnicity were not collected from any participant.",
          "paramType": "COUNT_OF_PARTICIPANTS",
          "unitOfMeasure": "Participants",
          "classes": [
            {
              "denoms": [
                {
                  "units": "Participants",
                  "counts": [
                    {
                      "groupId": "BG000",
                      "value": "0"
                    },
                    {
                      "groupId": "BG001",
                      "value": "0"
                    },
                    {
                      "groupId": "BG002",
                      "value": "0"
                    }
                  ]
                }
              ],
              "categories": [
                {
                  "measurements": [
                    {
                      "groupId": "BG002",
                      "value": "0"
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "title": "Region of Enrollment",
          "paramType": "COUNT_OF_PARTICIPANTS",
          "unitOfMeasure": "Participants",
          "classes": [
            {
              "title": "United Kingdom",
              "denoms": [
                {
                  "units": "Participants",
                  "counts": [
                    {
                      "groupId": "BG000",
                      "value": "32"
                    },
                    {
                      "groupId": "BG001",
                      "value": "15"
                    },
                    {
                      "groupId": "BG002",
                      "value": "47"
                    }
                  ]
                }
              ],
              "categories": [
                {
                  "measurements": [
                    {
                      "groupId": "BG000",
                      "value": "32"
                    },
                    {
                      "groupId": "BG001",
                      "value": "15"
                    },
                    {
                      "groupId": "BG002",
                      "value": "47"
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "title": "Diagnosis of asthma",
          "paramType": "COUNT_OF_PARTICIPANTS",
          "unitOfMeasure": "Participants",
          "classes": [
            {
              "denoms": [
                {
                  "units": "Participants",
                  "counts": [
                    {
                      "groupId": "BG000",
                      "value": "32"
                    },
                    {
                      "groupId": "BG001",
                      "value": "15"
                    },
                    {
                      "groupId": "BG002",
                      "value": "47"
                    }
                  ]
                }
              ],
              "categories": [
                {
                  "measurements": [
                    {
                      "groupId": "BG000",
                      "value": "20"
                    },
                    {
                      "groupId": "BG001",
                      "value": "12"
                    },
                    {
                      "groupId": "BG002",
                      "value": "32"
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "title": "Previous anaphylaxis to peanut",
          "paramType": "COUNT_OF_PARTICIPANTS",
          "unitOfMeasure": "Participants",
          "classes": [
            {
              "denoms": [
                {
                  "units": "Participants",
                  "counts": [
                    {
                      "groupId": "BG000",
                      "value": "32"
                    },
                    {
                      "groupId": "BG001",
                      "value": "15"
                    },
                    {
                      "groupId": "BG002",
                      "value": "47"
                    }
                  ]
                }
              ],
              "categories": [
                {
                  "measurements": [
                    {
                      "groupId": "BG000",
                      "value": "14"
                    },
                    {
                      "groupId": "BG001",
                      "value": "5"
                    },
                    {
                      "groupId": "BG002",
                      "value": "19"
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "title": "Skin prick test to commercial peanut allergen",
          "paramType": "MEDIAN",
          "dispersionType": "FULL_RANGE",
          "unitOfMeasure": "mm skin wheal",
          "classes": [
            {
              "denoms": [
                {
                  "units": "Participants",
                  "counts": [
                    {
                      "groupId": "BG000",
                      "value": "32"
                    },
                    {
                      "groupId": "BG001",
                      "value": "15"
                    },
                    {
                      "groupId": "BG002",
                      "value": "47"
                    }
                  ]
                }
              ],
              "categories": [
                {
                  "measurements": [
                    {
                      "groupId": "BG000",
                      "value": "9",
                      "lowerLimit": "3",
                      "upperLimit": "22"
                    },
                    {
                      "groupId": "BG001",
                      "value": "9",
                      "lowerLimit": "6",
                      "upperLimit": "17"
                    },
                    {
                      "groupId": "BG002",
                      "value": "9",
                      "lowerLimit": "3",
                      "upperLimit": "22"
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "title": "Serum IgE to peanut",
          "paramType": "MEDIAN",
          "dispersionType": "FULL_RANGE",
          "unitOfMeasure": "kUA/lL",
          "classes": [
            {
              "denoms": [
                {
                  "units": "Participants",
                  "counts": [
                    {
                      "groupId": "BG000",
                      "value": "32"
                    },
                    {
                      "groupId": "BG001",
                      "value": "15"
                    },
                    {
                      "groupId": "BG002",
                      "value": "47"
                    }
                  ]
                }
              ],
              "categories": [
                {
                  "measurements": [
                    {
                      "groupId": "BG000",
                      "value": "32.9",
                      "lowerLimit": "0.9",
                      "upperLimit": "412"
                    },
                    {
                      "groupId": "BG001",
                      "value": "38.7",
                      "lowerLimit": "1.2",
                      "upperLimit": "247"
                    },
                    {
                      "groupId": "BG002",
                      "value": "35.8",
                      "lowerLimit": "0.9",
                      "upperLimit": "412"
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "title": "Serum IgE to ara h 2",
          "paramType": "MEDIAN",
          "dispersionType": "FULL_RANGE",
          "unitOfMeasure": "kUA/lL",
          "classes": [
            {
              "denoms": [
                {
                  "units": "Participants",
                  "counts": [
                    {
                      "groupId": "BG000",
                      "value": "32"
                    },
                    {
                      "groupId": "BG001",
                      "value": "15"
                    },
                    {
                      "groupId": "BG002",
                      "value": "47"
                    }
                  ]
                }
              ],
              "categories": [
                {
                  "measurements": [
                    {
                      "groupId": "BG000",
                      "value": "17",
                      "lowerLimit": "0.5",
                      "upperLimit": "248"
                    },
                    {
                      "groupId": "BG001",
                      "value": "32.8",
                      "lowerLimit": "0.8",
                      "upperLimit": "173"
                    },
                    {
                      "groupId": "BG002",
                      "value": "17.4",
                      "lowerLimit": "0.5",
                      "upperLimit": "248"
                    }
                  ]
                }
              ]
            }
          ]
        }
      ]
    },
    "outcomeMeasuresModule": {
      "outcomeMeasures": [
        {
          "type": "PRIMARY",
          "title": "Desensitisation to >1.4g (Roasted) Peanut Protein at Food Challenge",
          "description": "The proportion of participants who tolerate 1.4g (or more) roasted peanut protein after 12 months of OIT as assessed by DBPCFC, in the active vs control group.",
          "reportingStatus": "POSTED",
          "paramType": "COUNT_OF_PARTICIPANTS",
          "unitOfMeasure": "Participants",
          "timeFrame": "12 months",
          "groups": [
            {
              "id": "OG000",
              "title": "Desensitisation to Peanut",
              "description": "Desensitisation using boiled peanut"
            },
            {
              "id": "OG001",
              "title": "Control",
              "description": "Subjects allocated to the control group will undergo routine care for 12 months, following which they will be offered the active treatment with boiled peanut (as a one-way cross-over intervention).\n\nDesensitisation using boiled peanut (deferred start)"
            }
          ],
          "denoms": [
            {
              "units": "Participants",
              "counts": [
                {
                  "groupId": "OG000",
                  "value": "32"
                },
                {
                  "groupId": "OG001",
                  "value": "15"
                }
              ]
            }
          ],
          "classes": [
            {
              "categories": [
                {
                  "measurements": [
                    {
                      "groupId": "OG000",
                      "value": "24"
                    },
                    {
                      "groupId": "OG001",
                      "value": "14"
                    }
                  ]
                }
              ]
            }
          ],
          "analyses": [
            {
              "groupIds": [
                "OG000",
                "OG001"
              ],
              "nonInferiorityType": "SUPERIORITY",
              "pValue": "<0.0001",
              "statisticalMethod": "Fisher Exact"
            }
          ]
        },
        {
          "type": "SECONDARY",
          "title": "Change in Threshold to Roasted Peanut After 6 and 12 Months of OIT",
          "description": "Relative change in clinical threshold (No observed adverse event level, NOAEL; Lowest observed adverse event level, LOAEL) to roasted peanut at 6 and 12 months.",
          "reportingStatus": "NOT_POSTED",
          "timeFrame": "6 and 12 months after study intervention",
          "denomUnitsSelected": "Participants"
        },
        {
          "type": "SECONDARY",
          "title": "Sustained Unresponsiveness After 4 Week Cessation of Maintenance OIT",
          "description": "Rate of sustained unresponsiveness after 4 week cessation of maintenance OIT at 1 year.",
          "reportingStatus": "NOT_POSTED",
          "timeFrame": "After 1 year of OIT",
          "denomUnitsSelected": "Participants"
        },
        {
          "type": "SECONDARY",
          "title": "Safety, Incidence of Adverse Event",
          "description": "Incidence of adverse allergic events during desensitisation protocol",
          "reportingStatus": "NOT_POSTED",
          "timeFrame": "12 months",
          "denomUnitsSelected": "Participants"
        },
        {
          "type": "SECONDARY",
          "title": "Quality of Life Measures",
          "description": "Quality of Life assessment and how this changes during peanut desensitisation.",
          "reportingStatus": "NOT_POSTED",
          "timeFrame": "6, 12 and 24 months",
          "denomUnitsSelected": "Participants"
        },
        {
          "type": "SECONDARY",
          "title": "Study Compliance",
          "description": "Compliance with study protocol",
          "reportingStatus": "NOT_POSTED",
          "timeFrame": "12 months",
          "denomUnitsSelected": "Participants"
        },
        {
          "type": "SECONDARY",
          "title": "Immunological Outcomes",
          "description": "Immunological outcome measures pre-, during and post- 12 months of OIT",
          "reportingStatus": "NOT_POSTED",
          "timeFrame": "Pre, 3, 6, and 12 months post start of OIT",
          "denomUnitsSelected": "Participants"
        },
        {
          "type": "OTHER_PRE_SPECIFIED",
          "title": "Change in Threshold in Peanut-allergic Subjects Found to be Tolerant to Boiled Peanut at Baseline",
          "description": "Change in threshold in peanut-allergic subjects found to be tolerant to boiled peanut at baseline, as determined by double-blind, placebo-controlled food challenges pre- and post- desensitisation.",
          "reportingStatus": "NOT_POSTED",
          "timeFrame": "12 months",
          "denomUnitsSelected": "Participants"
        }
      ]
    },
    "adverseEventsModule": {
      "frequencyThreshold": "5",
      "timeFrame": "1 year (2 years in control arm)",
      "eventGroups": [
        {
          "id": "EG000",
          "title": "Desensitisation to Peanut",
          "description": "Desensitisation using boiled peanut",
          "deathsNumAffected": 0,
          "deathsNumAtRisk": 32,
          "seriousNumAffected": 17,
          "seriousNumAtRisk": 32,
          "otherNumAffected": 32,
          "otherNumAtRisk": 32
        },
        {
          "id": "EG001",
          "title": "Control - Avoidance Phase",
          "description": "Subjects allocated to the control group will undergo routine care for 12 months, following which they will be offered the active treatment with boiled peanut (as a one-way cross-over intervention).",
          "deathsNumAffected": 0,
          "deathsNumAtRisk": 15,
          "seriousNumAffected": 6,
          "seriousNumAtRisk": 15,
          "otherNumAffected": 0,
          "otherNumAtRisk": 15
        },
        {
          "id": "EG002",
          "title": "Control - Desensitisation Phase",
          "description": "Subjects allocated to the control group underwent routine care (dietary avoidance) for 12 months, following which they were offered active treatment with boiled peanut (as a one-way cross-over intervention).",
          "deathsNumAffected": 0,
          "deathsNumAtRisk": 15,
          "seriousNumAffected": 3,
          "seriousNumAtRisk": 15,
          "otherNumAffected": 12,
          "otherNumAtRisk": 15
        }
      ],
      "seriousEvents": [
        {
          "term": "Uncomplicated anaphylaxis at hospital food challenge",
          "organSystem": "Immune system disorders",
          "assessmentType": "SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 25,
              "numAffected": 12,
              "numAtRisk": 32
            },
            {
              "groupId": "EG001",
              "numEvents": 10,
              "numAffected": 6,
              "numAtRisk": 15
            },
            {
              "groupId": "EG002",
              "numEvents": 0,
              "numAffected": 0,
              "numAtRisk": 15
            }
          ]
        },
        {
          "term": "Anaphylaxis due to dosing at home",
          "organSystem": "Immune system disorders",
          "assessmentType": "SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 21,
              "numAffected": 11,
              "numAtRisk": 32
            },
            {
              "groupId": "EG001",
              "numEvents": 0,
              "numAffected": 0,
              "numAtRisk": 15
            },
            {
              "groupId": "EG002",
              "numEvents": 4,
              "numAffected": 3,
              "numAtRisk": 15
            }
          ]
        },
        {
          "term": "Anaphylaxis not related to study intervention",
          "organSystem": "Immune system disorders",
          "assessmentType": "SYSTEMATIC_ASSESSMENT",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 2,
              "numAffected": 1,
              "numAtRisk": 32
            },
            {
              "groupId": "EG001",
              "numEvents": 0,
              "numAffected": 0,
              "numAtRisk": 15
            },
            {
              "groupId": "EG002",
              "numEvents": 1,
              "numAffected": 1,
              "numAtRisk": 15
            }
          ]
        }
      ],
      "otherEvents": [
        {
          "term": "Allergic reaction due to study intervention",
          "organSystem": "Immune system disorders",
          "assessmentType": "SYSTEMATIC_ASSESSMENT",
          "notes": "In year 1 of study",
          "stats": [
            {
              "groupId": "EG000",
              "numEvents": 1017,
              "numAffected": 32,
              "numAtRisk": 32
            },
            {
              "groupId": "EG001",
              "numEvents": 0,
              "numAffected": 0,
              "numAtRisk": 15
            },
            {
              "groupId": "EG002",
              "numEvents": 115,
              "numAffected": 12,
              "numAtRisk": 15
            }
          ]
        }
      ]
    },
    "moreInfoModule": {
      "certainAgreement": {
        "piSponsorEmployee": true
      },
      "pointOfContact": {
        "title": "Dr Paul Turner",
        "organization": "Imperial College London",
        "email": "p.turner@imperial.ac.uk",
        "phone": "+44 20 3312 7754"
      }
    }
  },
  "documentSection": {
    "largeDocumentModule": {
      "largeDocs": [
        {
          "typeAbbrev": "Prot_SAP",
          "hasProtocol": true,
          "hasSap": true,
          "hasIcf": false,
          "label": "Study Protocol and Statistical Analysis Plan",
          "date": "2018-06-05",
          "uploadDate": "2023-04-24T13:12",
          "filename": "Prot_SAP_000.pdf",
          "size": 2275745
        }
      ]
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-04"
    },
    "conditionBrowseModule": {
      "meshes": [
        {
          "id": "D021183",
          "term": "Peanut Hypersensitivity"
        }
      ],
      "ancestors": [
        {
          "id": "D000074924",
          "term": "Nut and Peanut Hypersensitivity"
        },
        {
          "id": "D005512",
          "term": "Food Hypersensitivity"
        },
        {
          "id": "D006969",
          "term": "Hypersensitivity, Immediate"
        },
        {
          "id": "D006967",
          "term": "Hypersensitivity"
        },
        {
          "id": "D007154",
          "term": "Immune System Diseases"
        }
      ]
    }
  },
  "hasResults": true
}